Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-25 @ 7:39 PM
Study NCT ID:
NCT03767335
Status:
COMPLETED
Last Update Posted:
2025-06-26
First Post:
2018-12-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Sponsor:
Menarini Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-05
First Submit QC Date:
None
Study First Post Date:
2018-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-25
Results First Submit QC Date:
None
Results First Post Date:
2025-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-09
Last Update Post Date:
2025-06-26
Last Update Post Date Type:
ACTUAL